Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Equity Average (2016 - 2025)

Marimed (MRMD) has disclosed Equity Average for 15 consecutive years, with $52.2 million as the latest value for Q4 2025.

  • Quarterly Equity Average fell 17.45% to $52.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.2 million through Dec 2025, down 17.45% year-over-year, with the annual reading at $54.3 million for FY2025, 14.81% down from the prior year.
  • Equity Average for Q4 2025 was $52.2 million at Marimed, down from $55.6 million in the prior quarter.
  • The five-year high for Equity Average was $80.4 million in Q3 2023, with the low at $11.4 million in Q1 2021.
  • Average Equity Average over 5 years is $53.3 million, with a median of $56.5 million recorded in 2025.
  • The sharpest move saw Equity Average skyrocketed 1482.31% in 2021, then fell 17.69% in 2025.
  • Over 5 years, Equity Average stood at $35.8 million in 2021, then skyrocketed by 52.49% to $54.6 million in 2022, then surged by 36.23% to $74.4 million in 2023, then decreased by 15.03% to $63.2 million in 2024, then fell by 17.45% to $52.2 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $52.2 million, $55.6 million, and $57.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.